| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
glucokinase regulator | 0.604 | 0.615 | 8.5E-19 |
|
phenotype | 0.100 | None | 1.000 | 4 | 1 | 2016 | 2019 | ||||||||
|
V-set immunoregulatory receptor | 0.573 | 0.654 | 0.76 |
|
phenotype | 0.100 | None | 1.000 | 3 | 1 | 2016 | 2019 | ||||||||
|
cadherin related 23 | 0.539 | 0.769 | 3.2E-06 |
|
phenotype | 0.100 | None | 1.000 | 3 | 1 | 2016 | 2019 | ||||||||
|
protein tyrosine phosphatase non-receptor type 22 | 0.438 | 0.846 | 3.5E-21 |
|
phenotype | 0.100 | None | 1.000 | 2 | 1 | 2016 | 2019 | ||||||||
|
coiled-coil domain containing 69 | 1.000 | 0.038 | 4.9E-12 |
|
phenotype | 0.100 | None | 1.000 | 2 | 1 | 2016 | 2019 | ||||||||
|
tripartite motif containing 58 | 0.769 | 0.115 | 1.3E-10 |
|
phenotype | 0.100 | None | 1.000 | 2 | 1 | 2016 | 2019 | ||||||||
|
ETS proto-oncogene 1, transcription factor | 0.444 | 0.731 | 0.78 |
|
phenotype | 0.100 | None | 1.000 | 2 | 1 | 2016 | 2019 | ||||||||
|
E2F transcription factor 2 | 0.599 | 0.692 | 0.26 |
|
phenotype | 0.100 | None | 1.000 | 2 | 1 | 2016 | 2019 | ||||||||
|
colony stimulating factor 1 | 0.473 | 0.808 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 2 | 1 | 2016 | 2019 | ||||||||
|
junction adhesion molecule like | 0.861 | 0.192 | 7.5E-04 |
|
phenotype | 0.100 | None | 1.000 | 2 | 1 | 2016 | 2019 | ||||||||
|
NLR family pyrin domain containing 3 | 0.361 | 0.962 | 8.1E-04 |
|
phenotype | 0.100 | None | 1.000 | 2 | 1 | 2016 | 2019 | ||||||||
|
coiled-coil domain containing 92 | 0.839 | 0.154 | 0.30 |
|
phenotype | 0.100 | None | 1.000 | 2 | 1 | 2016 | 2019 | ||||||||
|
polycomb group ring finger 3 | 1.000 | 0.077 | 0.95 |
|
phenotype | 0.100 | None | 1.000 | 2 | 1 | 2016 | 2019 | ||||||||
|
absent in melanoma 2 | 0.521 | 0.769 | 2.2E-09 |
|
phenotype | 0.100 | None | 1.000 | 2 | 1 | 2011 | 2019 | ||||||||
|
interferon gamma inducible protein 16 | 0.603 | 0.769 | 1.8E-11 |
|
phenotype | 0.100 | None | 1.000 | 2 | 1 | 2011 | 2019 | ||||||||
|
integrin subunit alpha L | 0.511 | 0.885 | 4.3E-03 |
|
phenotype | 0.100 | None | 1.000 | 2 | 1 | 2016 | 2019 | ||||||||
|
fatty acid desaturase 2 | 0.575 | 0.692 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 2 | 1 | 2016 | 2019 | ||||||||
|
activin A receptor like type 1 | 0.493 | 0.769 | 9.7E-04 |
|
phenotype | 0.100 | None | 1.000 | 2 | 1 | 2016 | 2019 | ||||||||
|
TNF receptor superfamily member 10c | 0.578 | 0.731 | 3.2E-06 |
|
phenotype | 0.100 | None | 1.000 | 2 | 1 | 2016 | 2019 | ||||||||
|
myosin IG | 0.861 | 0.231 | 4.4E-10 |
|
phenotype | 0.100 | None | 1.000 | 2 | 1 | 2016 | 2019 | ||||||||
|
C-X-C motif chemokine ligand 6 | 0.582 | 0.692 | 2.7E-09 |
|
phenotype | 0.100 | None | 1.000 | 2 | 1 | 2016 | 2019 | ||||||||
|
ataxin 2 | 0.482 | 0.808 | 0.85 |
|
phenotype | 0.100 | None | 1.000 | 2 | 1 | 2016 | 2019 | ||||||||
|
RAS p21 protein activator 2 | 0.579 | 0.769 | 7.4E-31 |
|
phenotype | 0.100 | None | 1.000 | 2 | 1 | 2016 | 2019 | ||||||||
|
MTOR associated protein, eak-7 homolog | 0.931 | 0.154 | 9.8E-18 |
|
phenotype | 0.100 | None | 1.000 | 2 | 1 | 2016 | 2019 | ||||||||
|
plasminogen activator, urokinase receptor | 0.536 | 0.731 | 5.3E-03 |
|
phenotype | 0.100 | None | 1.000 | 2 | 1 | 2016 | 2019 |